PARLIAMENTARY WRITTEN QUESTION
Cancer Drugs Fund (27 January 2016)

To ask the Secretary of State for Health, what steps his Department is taking to ensure that the recommendations from the Accelerated Access Review interim report and the Cancer Drugs Fund consultation are not contradictory.

Asked by:
Sir Nicholas Dakin (Labour)

The Accelerated Access Review's independent chair, Sir Hugh Taylor, is considering a range of options for accelerating patient access to innovative products, as set out in the interim report. The review team is working closely with NHS England to ensure that the review recommendations are aligned with emerging thinking on the Cancer Drugs Fund.

Answered by:
George Freeman (Conservative)
4 February 2016